They told me it was effective, and I knew mailing a Cologuard box back would be pretty dang easy.” Cologuard — a simple way ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Bernstein lifted its Guardant Health price target to $200 after UnitedHealth's Shield coverage decision. Here's what it means ...

Despite a significant setback, Grail's Galleri test still has a pathway to widespread adoption.

For Q2, according to Seeking Alpha, analysts are expecting normalized EPS of $1.28, GAAP EPS of $0.97, and $12.52bn of ...

The American Cancer Society updated its colorectal cancer screening guidelines May 27 to include new blood- and stool-based screening options, while making clear that the blood-based test is a last ...

STI screening in men a lot of times is not part of routine health maintenance, whereas with women, there are more touchpoints ...

Colon cancer is now the number one cancer killer in the U.S. of people ages 50 and younger, and yet many folks (at any age) ...

Following the close, the company gained a broad portfolio and differentiated pipeline aimed at early detection of cancer and personalized treatment decisions. This includes Cologuard, a non-invasive ...

The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

Rates of rectal cancer deaths are rising in adults under 50.

Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) and Infinite Epigenetics ™ (“Infinite Epigenetics,” “Infinite”) today issued the following shareholder update to provide ...